Phased Innovation Research in Cancer Prognosis and Prediction (R21/R33)

The summary for the Phased Innovation Research in Cancer Prognosis and Prediction (R21/R33) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Phased Innovation Research in Cancer Prognosis and Prediction (R21/R33): This funding opportunity announcement (FOA) solicits Phased Application (R21/R33) grant applications from applicant organizations that propose research projects to evaluate the utility and pilot the application of new strategies for determining prognosis or predicting response to therapy. This program will provide tools to improve clinical decision-making in the care of cancer patients. This FOA provides support for a first phase (R21) for initial technical development and proof-of-principle, and a second phase (R33) for further development, application, and evaluation of clinical utility. The first phase should produce data to demonstrate the technical feasibility of the study design proposed for the second phase, including the analytic performance of the assay or test system on samples comparable to those that will be used in the second phase. The second phase should be designed to test whether application of the strategy will provide clinical benefit to a defined set of cancer patients.
Federal Grant Title: Phased Innovation Research in Cancer Prognosis and Prediction (R21/R33)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-06-434
Type of Funding: Grant
CFDA Numbers: 93.394
CFDA Descriptions: Cancer Detection and Diagnosis Research
Current Application Deadline: May 07, 2009 Mult
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: May 23, 2006
Creation Date: Dec 05, 2008
Archive Date: Jun 07, 2009
Total Program Funding:
Maximum Federal Grant Award: $200,000
Minimum Federal Grant Award:
Expected Number of Awards: 10
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply. Applicants may submit more than one application, provided each application is scientifically distinct.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologi...
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Ca...
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate C...
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic...
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Ca...
Image-Guided Cancer Interventions (STTR [R41/R42])
An SBIR Initiative for Image-Guided Cancer Interventions (R43/R44)
In Vivo Cancer Imaging Exploratory/Developmental Grants
More Grants from the National Institutes of Health
Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (R01 Clinical ...
Specialized Programs of Research Excellence (SPOREs) in Cancer Health Disparities and Mino...
Strategies for Controlled Release of HIV Vaccines (SCORE-H) (R01 Clinical Trial Not Allowe...
NINDS Program Project Grant (P01 Clinical Trial Optional)
Centers for Research in Emerging Infectious Diseases (CREID) Network (U01 Clinical Trial N...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com